Paradoxically, despite the observed ratio increase in AD, subsequent analyses revealed no significant correlations between the p-tau/t-tau ratio and key disease indicators, including CSF tau levels, hippocampal atrophy, or neuropsychological test performance [54] (details shown in Table 2 and Appendix A, Table A2). Here, MAPT is linked to Alzheimer disease.